Advertisement
News
Advertisement

Boston Scientific CMO Dawkins: We're working on renal denervation too

Fri, 10/19/2012 - 2:14pm
Mass Device

Boston Scientific CMO Dr. Keith Dawkins says the medical device company is working on a renal denervation system to treat hypertension.

Boston Scientific

Boston Scientific (NYSE:BSX) is running an internal program to develop a renal denervation device, Dr. Keith Dawkins told MassDevice.com this week.

Heading into next week's Transcatheter Cardiovascular Therapies 2012 conference in Miami, the Natick, Mass.-based medical device company's global chief medical officer told us that BSX is planning to highlight several technologies at the show.

A single-electrode renal denervation system will go into its 1st human trials over "the next few months," Dawkins told us. Boston Scientific is also working on a double-electrode device, he added.

"We're looking at being able to reduce the time it takes to do an ablation," Dawkins said.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading